BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31740232)

  • 1. Correlation between RICTOR overexpression and amplification in advanced solid tumors.
    Bang H; Ahn S; Ji Kim E; Kim ST; Park HY; Lee J; Kim KM
    Pathol Res Pract; 2020 Jan; 216(1):152734. PubMed ID: 31740232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition.
    Kim ST; Kim SY; Klempner SJ; Yoon J; Kim N; Ahn S; Bang H; Kim KM; Park W; Park SH; Park JO; Park YS; Lim HY; Lee SH; Park K; Kang WK; Lee J
    Ann Oncol; 2017 Mar; 28(3):547-554. PubMed ID: 28028034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between immunohistochemistry and RICTOR fluorescence in situ hybridization amplification in small cell lung carcinoma.
    Krencz I; Sebestyen A; Papay J; Lou Y; Lutz GF; Majewicz TL; Khoor A
    Hum Pathol; 2019 Nov; 93():74-80. PubMed ID: 31454632
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Krencz I; Sztankovics D; Sebestyén A; Pápay J; Dankó T; Moldvai D; Lutz E; Khoor A
    Pathol Oncol Res; 2024; 30():1611593. PubMed ID: 38706776
    [No Abstract]   [Full Text] [Related]  

  • 5. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
    Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
    Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction.
    Kim MA; Jung EJ; Lee HS; Lee HE; Jeon YK; Yang HK; Kim WH
    Hum Pathol; 2007 Sep; 38(9):1386-93. PubMed ID: 17555797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel RICTOR amplification harbouring entities: FISH validation of RICTOR amplification in tumour tissue after next-generation sequencing.
    Sztankovics D; Krencz I; Moldvai D; Dankó T; Nagy Á; Nagy N; Bedics G; Rókusz A; Papp G; Tőkés AM; Pápay J; Sápi Z; Dezső K; Bödör C; Sebestyén A
    Sci Rep; 2023 Nov; 13(1):19610. PubMed ID: 37949943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues.
    Kobayashi M; Ooi A; Oda Y; Nakanishi I
    Hum Pathol; 2002 Jan; 33(1):21-8. PubMed ID: 11823970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
    Sauer T; Wiedswang G; Boudjema G; Christensen H; Karesen R
    APMIS; 2003 Mar; 111(3):444-50. PubMed ID: 12752225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.
    Yano T; Doi T; Ohtsu A; Boku N; Hashizume K; Nakanishi M; Ochiai A
    Oncol Rep; 2006 Jan; 15(1):65-71. PubMed ID: 16328035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging system.
    Ciampa A; Xu B; Ayata G; Baiyee D; Wallace J; Wertheimer M; Edmiston K; Khan A
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):132-7. PubMed ID: 16785779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong HER-2/neu protein overexpression by immunohistochemistry often does not predict oncogene amplification by fluorescence in situ hybridization.
    Hammock L; Lewis M; Phillips C; Cohen C
    Hum Pathol; 2003 Oct; 34(10):1043-7. PubMed ID: 14608539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.
    Tafe LJ; Janjigian YY; Zaidinski M; Hedvat CV; Hameed MR; Tang LH; Hicks JB; Shah MA; Barbashina V
    Arch Pathol Lab Med; 2011 Nov; 135(11):1460-5. PubMed ID: 22032573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu overexpression is an independent prognostic factor for intestinal-type and early-stage gastric cancer patients.
    Liu W; Zhong S; Chen J; Yu Y
    J Clin Gastroenterol; 2012 Apr; 46(4):e31-7. PubMed ID: 22064554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract.
    Rossi E; Villanacci V; Danesino C; Donato F; Nascimbeni R; Bassotti G
    Rev Esp Enferm Dig; 2011 Dec; 103(12):632-9. PubMed ID: 22217347
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kim LC; Rhee CH; Chen J
    Mol Cancer Res; 2020 Nov; 18(11):1675-1684. PubMed ID: 32801163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.
    Pauletti G; Dandekar S; Rong H; Ramos L; Peng H; Seshadri R; Slamon DJ
    J Clin Oncol; 2000 Nov; 18(21):3651-64. PubMed ID: 11054438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HER2 gene amplification and overexpression in advanced gastric cancer].
    Roa I; Slater J; Carvajal D; Schalper K; de Toro G; Ares R; Game A; León J; de Aretxabala X
    Rev Med Chil; 2013 Nov; 141(11):1411-9. PubMed ID: 24718467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancer.
    El Shamieh S; Saleh F; Moussa S; Kattan J; Farhat F
    Pharmacogenomics; 2018 Jun; 19(9):757-760. PubMed ID: 29790419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2.
    Guo Z; Zhang X; Zhu H; Zhong N; Luo X; Zhang Y; Tu F; Zhong J; Wang X; He J; Huang L
    Oncol Rep; 2021 Feb; 45(2):523-534. PubMed ID: 33416177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.